Lucid Diagnostics News

Lucid Diagnostics | 10-Q: Q2 2024 Earnings Report

Aug 12 08:35 ET

Lucid Diagnostics | 8-K: Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Aug 12 08:20 ET

Lucid Diagnostics | 8-K: Current report

Jul 24 13:33 ET

Lucid Diagnostics | 424B3: Prospectus

Jul 19 09:07 ET

Lucid Diagnostics | EFFECT: Others

Jul 19 06:06 ET

Lucid Diagnostics | CORRESP: CORRESP

Jul 15 13:30 ET

Lucid Diagnostics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Jul 12 16:35 ET

Lucid Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%), etc.

Jul 8 15:53 ET

Lucid Diagnostics | UPLOAD: Others

Jul 8 13:30 ET

Lucid Diagnostics | S-3: Registration statement for specified transactions by certain issuers

Jul 1 17:30 ET

Lucid Diagnostics | 8-K: Current report

Jun 21 17:17 ET

Lucid Diagnostics | DEF 14A: Definitive information statements

Jun 6 09:51 ET

Lucid Diagnostics | DEFA14A: Others

Jun 6 08:41 ET

Lucid Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 24 17:28 ET

Lucid Diagnostics | DEFA14A: Others

May 24 16:39 ET

Lucid Diagnostics | 8-K: Current report

May 24 16:35 ET

Lucid Diagnostics | 8-K: Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

May 14 06:09 ET

Lucid Diagnostics | 10-Q: Q1 2024 Earnings Report

May 13 08:24 ET

Lucid Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Matheis Dennis

May 9 22:03 ET

Lucid Diagnostics | 3: Initial statement of beneficial ownership of securities-Director Matheis Dennis

May 9 22:03 ET